« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 5
, Pages
914-920
, November 2008
Anti-cockroach and anti-mouse IgE are associated with early wheeze and atopy in an inner-city birth cohort
-
Frequency of anti-cockroach and anti-mouse IgE by age 3 years (n = 404). The percentage of children with anti-cockroach IgE or anti-mouse IgE of 0.35 IU/mL or greater by age 3 years is shown. Black ba
Frequency of anti-cockroach and anti-mouse IgE by age 3 years (n = 404). The percentage of children with anti-cockroach IgE or anti-mouse IgE of 0.35 IU/mL or greater by age 3 years is shown. Black bars represent the percentage of children in each group with IgE to both cockroach and mouse.
-
Total IgE is linearly correlated with anti-cockroach IgE levels. Spearman's rho for cockroach at age 2 years: r = 0.618 (P < .002, not displayed); Spearman's rho for cockroach at age 3 years: r = 0.52Total IgE is linearly correlated with anti-cockroach IgE levels. Spearman's rho for cockroach at age 2 years: r = 0.618 (P < .002, not displayed); Spearman's rho for cockroach at age 3 years: r = 0.528 (P < .003); Spearman's rho for mouse at age 2 years: r = 0.298 (P = .147, not displayed); Spearman's rho for mouse at age 3 years: r = 0.220 (P = .326).
-
Increased odds of wheeze and atopy with anti-cockroach and anti-mouse IgE. B, Both anti-mouse IgE and anti-cockroach IgE of 0.35 IU/mL or greater; M, anti-mouse IgE of 0.35 IU/mL or greater; C, anti-cIncreased odds of wheeze and atopy with anti-cockroach and anti-mouse IgE. B, Both anti-mouse IgE and anti-cockroach IgE of 0.35 IU/mL or greater; M, anti-mouse IgE of 0.35 IU/mL or greater; C, anti-cockroach IgE of 0.35 IU/mL or greater. ∗P < .05 and ∗∗P < .005 on logistic regression analysis.
-
Increased prevalence of wheeze, rhinitis, and atopic dermatitis with higher IgE class (n = 404). ∗∗P < .005 on test for trend for anti-cockroach and anti-mouse IgE class. ∗P < 0.05 on test for trend fIncreased prevalence of wheeze, rhinitis, and atopic dermatitis with higher IgE class (n = 404). ∗∗P < .005 on test for trend for anti-cockroach and anti-mouse IgE class. ∗P < 0.05 on test for trend for anti-mouse IgE class. Anti-cockroach IgE class 0, n = 358; class 1, n = 11; class 2 or greater, n = 35. Anti-mouse IgE class 0, n = 364; class 1, n = 9; class 2 or greater, n = 31.
Supported by the National Institute of Environmental Health Sciences (grant nos. 5 P01 ES009600, 5 R01 ES008977, and P30 ES009089), the US Environmental Protection Agency (grant nos. R827027 and RD-832141), the Irving General Clinical Research Center (grant no. RR00645), the Educational Foundation of America, the Horace W. Goldsmith Foundation, the Gladys & Roland Harriman Foundation, The John Merck Fund, The New York Community Trust, and the Trustees of the Blanchette Hooker Rockefeller Fund.
Disclosure of potential conflict of interest: M. S. Perzanowski has received grant from the National Institutes of Health (NIH). G. L. Chew has received grants from the National Institute of Environmental Health Sciences. R. L. Miller has received grants or other research funding from the NIH, the Environmental Protection Agency, and the Sandler Program for Asthma Research. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01667-9
doi: 10.1016/j.jaci.2008.08.034
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 5
, Pages
914-920
, November 2008
